Bristol-Myers Squibb Company Common Stock (BMY): Cramer News

BMY – Cautious commentary on Mad Money show.


Key Facts Surrounding This News Item


  • BMY had a POWR Rating of C (Neutral) coming into today.
  • BMY was 1.64% above its 10-Day Moving Average coming into today.
  • BMY was 1.26% above its 20-Day Moving Average coming into today.
  • BMY was -10.36% below its 50-Day Moving Average coming into today.
  • BMY was -13.85% below its 100-Day Moving Average coming into today.
  • BMY was -13.64% below its 200-Day Moving Average coming into today.
  • BMY had returned -13.54% year-to-date leading up to today’s news, versus a +2.00% return from the benchmark S&P 500 during the same period.

More Info About Bristol-Myers Squibb Company Common Stock (BMY)


Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It provides chemically-synthesized drugs or small molecules, and biologics in various therapeutic areas, including virology comprising human immunodeficiency virus infection (HIV); oncology; neuroscience; immunoscience; and cardiovascular. The company was founded in 1887 and is based in New York, New York. View our full BMY ticker page with ratings, news, and more.

BMY at a Glance

BMY Current POWR Rating™
Overall POWR Rating™
BMY Current Price $52.12 2.83%
More BMY Ratings, Data, and News

BMY Price Reaction

The day of this event (May. 16, 2018)
BMY Closing Price$51.50 0.17%
BMY Volume5,491,582
25.46% from avg
Leading up to this event
BMY 1-mo return3.29%
After this event
BMY 1-day return0.83%
BMY 3-day return0.11%
BMY 5-day return0.38%

BMY Price Chart


The Top Stocks For 2019

More Bristol-Myers Squibb Company Common Stock (BMY) News View All

Event/Date Symbol News Detail Start Price End Price Change POWR Rating
Loading, please wait...
View All BMY News
Page generated in 0.8056 seconds.